Company intelligence / Profile preview

QIMA Life Sciences

Ownership: Private
Employees: ~150
Development stage: Other

Overview

QIMA Life Sciences does not have its own clinical results or pipeline. It provides contract research services including in silico prediction, preclinical efficacy evaluation (in vitro, ex vivo), and clinical evaluations for cosmetics, nutraceuticals, dermatology products, pharmaceuticals and biotech companies. The company specializes in claim substantiation and drug candidate discovery support using advanced biological models and analytical platforms.

Therapeutic areas: DermatologyImmunology
Modalities: Small moleculeBiologicPeptidesCell and tissue-based assaysIn silico testing (AI-driven prediction)
Industry: Drug Discovery Services

Partnerships

Not specifically disclosed; works with international brands/distributors/manufacturers across pharma/cosmetics/nutraceutical sectors.

Beyond the preview

Go deeper on QIMA Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QIMA Life Sciences.

Explore the full profile